Ola Olén (O Olén)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Gut

Clinical epidemiology

Alimentary pharmacology & therapeutics

Nutrients

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Karolinska Institutet Jan 1o 2005 - Sep 12o 2008

Sweden

PHD :: Department of Clinical Science and Education

Publications

Erland Axelsson, Dorian Kern, Erik Hedman-Lagerlöf, Perjohan Lindfors, Josefin Palmgren, Hugo Hesser, Erik Andersson, Robert Johansson, Ola Olén, Marianne Bonnert, Maria Lalouni, Brjánn Ljótsson
Psychological treatments for irritable bowel syndrome: a comprehensive systematic review and meta-analysis. Cognitive behaviour therapy (2023)
Jiangwei Sun, Bjorn Roelstraete, Emma Svennberg, Jonas Halfvarson, Johan Sundström, Anders Forss, Ola Olén, Jonas F Ludvigsson
Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study. PLoS medicine 20 (10) (2023)
Jiangwei Sun, Jonas Halfvarson, Peter Appelros, David Bergman, Fahim Ebrahimi, Bjorn Roelstraete, Ola Olén, Jonas F Ludvigsson
Long-term Risk of Stroke in Patients With Inflammatory Bowel Disease: A Population-Based, Sibling-Controlled Cohort Study, 1969-2019. Neurology (2023)
Adam S Faye, Jordan E Axelrad, Jiangwei Sun, Jonas Halfvarson, Jonas Söderling, Ola Olén, Jonas F Ludvigsson
Atherosclerosis as a Risk Factor for IBD: A Population-Based Case-Control Study. The American journal of gastroenterology (2023)
Emily Walsh Lopes, Simon S M Chan, Mingyang Song, Jonas F Ludvigsson, Niclas Håkansson, Paul Lochhead, Allan Clark, Kristin E Burke, Ashwin N Ananthakrishnan, Amanda J Cross, Domenico Palli, Manuela M Bergmann, James M Richter, Andrew T Chan, Ola Olén, Alicja Wolk, Hamed Khalili, null null
Lifestyle factors for the prevention of inflammatory bowel disease. Gut (2022)
Åsa H Everhov, Ola Olén
Editorial: colorectal cancer in elderly-onset IBD-what is the risk? Authors' reply. Alimentary pharmacology & therapeutics 56 (9) (2022)
Jonas F Ludvigsson, Jiangwei Sun, Ola Olén, Mingyang Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Fang Fang
Normal Gastrointestinal Mucosa at Biopsy and Overall Mortality: Nationwide Population-Based Cohort Study. Clinical epidemiology 14 (2022)
Emily Walsh Lopes, Simon S M Chan, Mingyang Song, Jonas F Ludvigsson, Niclas Håkansson, Paul Lochhead, Allan Clark, Kristin E Burke, Ashwin N Ananthakrishnan, Amanda J Cross, Domenico Palli, Manuela M Bergmann, James M Richter, Andrew T Chan, Ola Olén, Alicja Wolk, Hamed Khalili, null null
Lifestyle factors for the prevention of inflammatory bowel disease. Gut (2022)
Natalia Mouratidou, Petter Malmborg, Jacob Järås, Vignir Sigurdsson, Olof Sandström, Ulrika L Fagerberg, Gabriella Bröms, Jonas F Ludvigsson, Ola Olén, null null
Identification of Childhood-Onset Inflammatory Bowel Disease in Swedish Healthcare Registers: A Validation Study. Clinical epidemiology 14 (2022)
Åsa H Everhov, Michael C Sachs, Jonas F Ludvigsson, Hamed Khalili, Johan Askling, Martin Neovius, Pär Myrelid, Jonas Halfvarson, Caroline Nordenvall, Jonas Söderling, Ola Olén, null null
Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study. Clinical epidemiology 12 (2020)
Jordan E Axelrad, Ola Olén, Michael C Sachs, Rune Erichsen, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Henrik Toft Sørensen, Jonas F Ludvigsson
Reply: Survival in Crohn's disease-associated small bowel adenocarcinoma. Gut 70 (5) (2020)
Hamed Khalili, Niclas Håkansson, Simon S Chan, Ye Chen, Paul Lochhead, Jonas F Ludvigsson, Andrew T Chan, Andrew R Hart, Ola Olén, Alicja Wolk
Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies. Gut 69 (9) (2020)
Jordan E Axelrad, Michael C Sachs, Jonas F Ludvigsson, Ola Olén, null null
A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data. Clinical epidemiology 12 (2020)
Jordan E Axelrad, Ola Olén, Michael C Sachs, Rune Erichsen, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Henrik Toft Sørensen, Jonas F Ludvigsson
Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden. Gut 70 (2) (2020)
Åsa H Everhov, Jonas F Ludvigsson, Ola Olén
Letter: phenotype and natural history of elderly onset inflammatory bowel disease. Alimentary pharmacology & therapeutics 47 (10) (2019)
Ola Olén, Johan Askling, Michael C Sachs, Martin Neovius, Karin E Smedby, Anders Ekbom, Jonas F Ludvigsson
Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014. Gut 69 (3) (2019)
Jennifer L P Protudjer, Ola Olén, Mirja Vetander, Inger Kull, Erik Melén, Marianne van Hage, Magnus Wickman, Anna Bergström
Milk-Related Symptoms and Immunoglobulin E Reactivity in Swedish Children from Early Life to Adolescence. Nutrients 10 (5) (2018)
Maria Lalouni, Brjánn Ljótsson, Marianne Bonnert, Erik Hedman-Lagerlöf, Jens Högström, Eva Serlachius, Ola Olén
Internet-Delivered Cognitive Behavioral Therapy for Children With Pain-Related Functional Gastrointestinal Disorders: Feasibility Study. JMIR mental health 4 (3) (2017)

Ola Olén.css-eqlu8i{font-size:small;padding-left:4px;} (O Olén)

Publication Activity (10 Years)

Top Topics

Top Venues

Ola Olén (O Olén)